Exclusive: ACR Convergence 2024| Focus Rheums

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

RA Treatment May Be Beneficial Even After Patients Meet Remission Criteria

  |  Issue: May 2011  |  

“We’re still waiting for the radiographic data, which will allow us to look at the association between the MRI inflammatory joint scores and the X-rays that were obtained,” Dr. Ranganath says.

The investigators also plan to study whether there are any differences between the inflammatory joint scores based on the treatment the patient received during the TEAR trial. Going forward, they will review the data to determine the relationship, if any, between the inflammatory joint scores and the duration of sustained clinical remission before the MRI.

ADVERTISEMENT
SCROLL TO CONTINUE

Reference

  1. Brown AK, Quinn MA, Karim Z, et al. Presence of significant synovitis in rheumatoid arthritis patients with disease-modifying antirheumatic drug-induced clinical remission: Evidence from an imaging study may explain structural progres­sion. Arthritis Rheum. 2006;54:3761-3773.

Help Find a Cure for RA

To make a pledge or one-time donation to the REF for the Within Our Reach: Finding a Cure for Rheumatoid Arthritis campaign, visit www.rheumatology.org/REF. For more information about the Within Our Reach campaign and to read about grant projects, visit www.WithinOurReach.info.

Related Articles

    Does MRI Differentiate Osteoarthritis and Meniscal Tear in Knee Pain?

    When a young patient arrives at a clinic complaining of knee pain with clicking or popping, a meniscal tear is often the culprit. “In young [people], there’s a pretty classic presentation of meniscal tear, with clicking and other mechanical symptoms, because the tear rubs up against different tissues,” says Jeffrey Katz, MD, MSc, a rheumatologist…

    Engaging Patients to Enhance Rheumatology Research

    It takes a great deal of time and money to produce clinical practice guidelines for rheumatic diseases. No matter how well a treatment inhibits inflammatory cytokines, it won’t lower disease activity without one essential factor: patient compliance. “You can’t propose a treatment algorithm in your research that no patient would actually use,” says Veena Ranganath,…

    Lacrimal & Tear Fluid Yield Clues to Dry Eye Disease

    A recent study suggests novel markers of dry eye disease can be found in the lacrimal fluid and tear fluid of patients. Researchers analyzed the proteins in these fluids and found immune response-related proteins are upregulated at the protein level in lacrimal fluid of patients with dry eye disease and may be an important biomarker…